<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02760979</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-DEN-2012-24</org_study_id>
    <secondary_id>2012-001285-15</secondary_id>
    <nct_id>NCT02760979</nct_id>
  </id_info>
  <brief_title>The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty</brief_title>
  <official_title>The Efficacy of Denosumab in Decreasing Periprosthetic Bone Loss in Patients With Total Knee Arthroplasty: A Randomised, Double Blind, Placebo Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of Denosumab in decreasing the periprosthetic bone resorption
      after Total Knee Arthroplasty compared to placebo in 60 patients (30 placebo and 30
      Denosumab) within a year after surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periprosthetic bone resorption after Total Knee Arthroplasty occurs as a consequence of
      prosthetic implant on the bone. Some of this patients (up to 13%) develop an aseptic failure
      of the prosthesis needing revision surgery.

      2 groups of patients are treated with Placebo and Denosumab in a double blind prospective
      trial. Densitometry, Knee society score (KSS), Western Ontario McMaster University
      Osteoarthritis Index (WOMAC) and the Medical Outcomes Study Short Form 36 (SF-36) were done
      in both groups at 0,3,6 and 12 months after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Bone Mass index</measure>
    <time_frame>Change in densitometry before surgery (0) and at three (3) months after surgery</time_frame>
    <description>Bone Mass index in gr/cm3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Bone Mass index</measure>
    <time_frame>Change in densitometry before surgery (0) and at six (6) months after surgery</time_frame>
    <description>Bone Mass index in gr/cm3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Bone Mass index</measure>
    <time_frame>Change in densitometry before surgery (0) and at twelve (12) months after surgery</time_frame>
    <description>Bone Mass index in gr/cm3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (WOMAC)</measure>
    <time_frame>WOMAC test before (0) and at three (3), six (6) and twelve (12) months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (SF-36)</measure>
    <time_frame>SF-36 test before (0) and at three (3), six (6) and twelve (12) months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kidney function</measure>
    <time_frame>Before surgery and at three, six and twelve months after surgery</time_frame>
    <description>Creatinine clearance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver function</measure>
    <time_frame>Before surgery and at three, six and twelve months after surgery</time_frame>
    <description>ALT, AST</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone turnover markers</measure>
    <time_frame>At three, six and twelve months after surgery</time_frame>
    <description>Beta cross lap and Procollagen type 1 n-terminal propeptide (P1NP)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Bone Resorption</condition>
  <arm_group>
    <arm_group_label>Denosumab</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with Denosumab</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients treated with placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Denosumab</intervention_name>
    <description>Denosumab treatment one year after surgery</description>
    <arm_group_label>Denosumab</arm_group_label>
    <other_name>Prolia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Serum one year after surgery</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Serum</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Knee Osteoarthritis treated with Total Knee Arthroplasty

        Exclusion Criteria:

          -  Patients allergies to Denosumab

          -  Patients with previous Osteoporosis treatment

          -  Patients with renal failure

          -  Patients with previous Bisphosphonate treatment for more than 5 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Carlos Gonzalez</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic Department-Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <reference>
    <citation>Ishii Y, Yagisawa K, Ikezawa Y. Changes in bone mineral density of the proximal femur after total knee arthroplasty. J Arthroplasty. 2000 Jun;15(4):519-22.</citation>
    <PMID>10884214</PMID>
  </reference>
  <reference>
    <citation>Sugita T, Umehara J, Sato K, Inoue H. Influence of tibial bone quality on loosening of the tibial component in total knee arthroplasty for rheumatoid arthritis: long-term results. Orthopedics. 1999 Feb;22(2):213-5.</citation>
    <PMID>10037335</PMID>
  </reference>
  <reference>
    <citation>Wang CJ, Wang JW, Weng LH, Hsu CC, Huang CC, Chen HS. The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty. J Bone Joint Surg Am. 2003 Nov;85-A(11):2121-6.</citation>
    <PMID>14630840</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2016</study_first_submitted>
  <study_first_submitted_qc>May 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2016</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Resorption</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Denosumab</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

